89 related articles for article (PubMed ID: 16359372)
1. Marked erythrocyte microcytosis under primary immunosuppression with sirolimus.
Kim MJ; Mayr M; Pechula M; Steiger J; Dickenmann M
Transpl Int; 2006 Jan; 19(1):12-8. PubMed ID: 16359372
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine.
El Haggan W; Ficheux M; Debruyne D; Rognant N; Lobbedez T; Allard C; Coquerel A; Ryckelynck JP; Hurault de Ligny B
Transplant Proc; 2005 Mar; 37(2):864-6. PubMed ID: 15848558
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus-based regimen is associated with decreased expression of glomerular vascular endothelial growth factor.
Vuiblet V; Birembaut P; François A; Cordonnier C; Noel LH; Goujon JM; Paraf F; Machet MC; Girardot-Seguin S; Lebranchu Y; Rieu P
Nephrol Dial Transplant; 2012 Jan; 27(1):411-6. PubMed ID: 21617191
[TBL] [Abstract][Full Text] [Related]
4. Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function.
Friend P; Russ G; Oberbauer R; Murgia MG; Tufveson G; Chapman J; Blancho G; Mota A; Grandaliano G; Campistol JM; Brault Y; Burke JT;
Transpl Int; 2007 Sep; 20(9):754-60. PubMed ID: 17565578
[TBL] [Abstract][Full Text] [Related]
5. Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment.
Pliszczynski J; Kahan BD
Transplant Proc; 2011 Dec; 43(10):3657-68. PubMed ID: 22172822
[TBL] [Abstract][Full Text] [Related]
6. The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients.
Flechner SM; Zhou L; Derweesh I; Mastroianni B; Savas K; Goldfarb D; Modlin CS; Krishnamurthi V; Novick A
Transplantation; 2003 Dec; 76(12):1729-34. PubMed ID: 14688524
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus attenuates the rate of progression of early chronic allograft nephropathy.
Sumethkul V; Changsirikulchai S; Lothuvachai T; Chalermsanyakorn P
Transplant Proc; 2006 Dec; 38(10):3470-2. PubMed ID: 17175307
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen.
Sampaio EL; Pinheiro-Machado PG; Garcia R; Felipe CR; Park SI; Casarini DE; Moreira S; Franco MF; Tedesco-Silva H; Medina-Pestana JO
Clin Transplant; 2008; 22(2):141-9. PubMed ID: 18339132
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury.
Ruggenenti P; Perico N; Gotti E; Cravedi P; D'Agati V; Gagliardini E; Abbate M; Gaspari F; Cattaneo D; Noris M; Casiraghi F; Todeschini M; Cugini D; Conti S; Remuzzi G
Transplantation; 2007 Oct; 84(8):956-64. PubMed ID: 17989600
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus and mycophenolate mofetil after liver transplantation.
Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Tscheliessnigg KH
Transpl Int; 2003 Jul; 16(7):504-9. PubMed ID: 12687325
[TBL] [Abstract][Full Text] [Related]
11. Anaemia, microcytosis and sirolimus--is iron the missing link?
Sofroniadou S; Kassimatis T; Goldsmith D
Nephrol Dial Transplant; 2010 May; 25(5):1667-75. PubMed ID: 20054028
[TBL] [Abstract][Full Text] [Related]
12. Influence of sirolimus on proteinuria in de novo kidney transplantation with expanded criteria donors: comparison of two CNI-free protocols.
Diekmann F; Gutiérrez-Dalmau A; López S; Cofán F; Esforzado N; Ricart MJ; Rossich E; Saval N; Torregrosa JV; Oppenheimer F; Campistol JM
Nephrol Dial Transplant; 2007 Aug; 22(8):2316-21. PubMed ID: 17452413
[TBL] [Abstract][Full Text] [Related]
13. Observations on quadruple immunosuppression maintenance therapy using rapamycin, low-dose cyclosporine, mycophenolate mofetil, and prednisone following ATG induction.
Khauli RB; Houjaij A; Sawah S; El-Hout Y; Medawwar W; Hussein M; Habbal A; Daouk M; Uwaydah M; Maacaron H; Abdelnoor A
Transplant Proc; 2005 Sep; 37(7):3031-3. PubMed ID: 16213295
[TBL] [Abstract][Full Text] [Related]
14. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
[TBL] [Abstract][Full Text] [Related]
15. Individualization of immunosuppressive therapy. II. Sirolimus as a less nephrotoxic alternative to calcineurin inhibitors.
Lisik W; Kahan BD
Transplant Proc; 2006; 38(1):69-73. PubMed ID: 16504667
[TBL] [Abstract][Full Text] [Related]
16. Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs.
Flechner SM; Goldfarb D; Solez K; Modlin CS; Mastroianni B; Savas K; Babineau D; Kurian S; Salomon D; Novick AC; Cook DJ
Transplantation; 2007 Apr; 83(7):883-92. PubMed ID: 17460558
[TBL] [Abstract][Full Text] [Related]
17. New approaches to de novo immunosuppression and steroid elimination.
Lebranchu Y
Transplant Proc; 2009; 41(6 Suppl):S39-41. PubMed ID: 19651295
[TBL] [Abstract][Full Text] [Related]
18. Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study.
Lebranchu Y; Thierry A; Toupance O; Westeel PF; Etienne I; Thervet E; Moulin B; Frouget T; Le Meur Y; Glotz D; Heng AE; Onno C; Buchler M; Girardot-Seguin S; Hurault de Ligny B
Am J Transplant; 2009 May; 9(5):1115-23. PubMed ID: 19422337
[TBL] [Abstract][Full Text] [Related]
19. Reduction in erythropoietin resistance after conversion from sirolimus to enteric coated mycophenolate sodium.
Augustine JJ; Rodriguez V; Padiyar A; Bodziak KA; Schulak JA; Hricik DE
Transplantation; 2008 Aug; 86(4):548-53. PubMed ID: 18724224
[TBL] [Abstract][Full Text] [Related]
20. Combined use of tacrolimus and sirolimus in de novo renal transplant patients: current data.
Ribes D; Kamar N; Esposito L; Rostaing L
Transplant Proc; 2005; 37(6):2813-6. PubMed ID: 16182816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
